<DOC>
	<DOC>NCT01862848</DOC>
	<brief_summary>To evaluate the change in patient pain perception with the use of a topical compounded pain cream regimen.</brief_summary>
	<brief_title>Topical Compounded Pain Creams And Pain Perception (TOPCAPP)</brief_title>
	<detailed_description>This is a prospective,observational,single center, open label study of patients that receive a combination topical compounded analgesic medication with no comparator group.</detailed_description>
	<criteria>Participants must be diagnosed with an ICD9 code indicative of chronic pain. Participants must be starting a new regimen of topical therapy with multiple compounded agents. Participants must be expecting to receive therapy for at least 12 weeks. Participants must be between 18 and 65 years of age. Participants must be able to provide sound written and verbal informed consent. Participants must not have prior hypersensitivity or adverse events to any of the components in the customized prescription. Participants must not be pregnant or breastfeeding women. Participants must not have a diagnosis of cancer within the past 5 years.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Topical Compounded Pain Creams and Pain Perception</keyword>
</DOC>